IRT Support for a Long-Term, Complex Rare Disease Study
Everest deployed its in-house IRT/RTSM technology, in addition to its expert team, to help the sponsor overcome several supply and dosing management challenges during a global, open-label extension study.
Read More16,000-Patient, Global Respiratory Trial that was Findings Free
Everest provided biometrics and IWRS support to a large-scale, global Phase III trial spanning 26 countries. The FDA and EMA Inspection Reports had 0 inspection findings on the work performed by Everest.
Read More